Janux Therapeutics Inc (NQ: JANX )
45.92
+1.24
(+2.79%)
Streaming Delayed Price
Updated: 12:08 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Janux Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/07/17/janx.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230717647990/en/1842329/22/6c4a43c4-28b0-47dd-b4e6-a0e5d6c43d42.jpg)
![](https://mms.businesswire.com/media/20230717429404/en/1842325/22/5070898csitelogo_Janux_Logo_RGB_72_%281%29.jpg)
![](/next-assets/images/schema-image-default.png)
Janux Therapeutics: Q1 Earnings Insights
May 09, 2023
Via Benzinga
Janux Therapeutics's Return On Capital Employed Overview
December 22, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/705792/dnaphoto.jpg)
![](https://mms.businesswire.com/media/20230605005059/en/1052726/5/janux-logo-web_page_01.jpg)
![](https://mms.businesswire.com/media/20230509006173/en/1788530/22/sitelogo_Janux_Logo_RGB_72.jpg)
![](https://mms.businesswire.com/media/20230424005872/en/1772598/22/Logo.jpg)
![](https://mms.businesswire.com/media/20230420005890/en/1538478/5/janux-logo-web_page_01.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_6235.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230310005380/en/1735889/22/Picture1.jpg)
![](https://mms.businesswire.com/media/20230214005399/en/1712872/22/Logo.jpg)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's After-Market Session
February 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/01/image_2.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221227005015/en/1672146/22/Logo.jpg)
![](https://mms.businesswire.com/media/20221122005368/en/1538478/5/janux-logo-web_page_01.jpg)
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/10/valuestocks_1600_04.jpg)
![](https://mms.businesswire.com/media/20221110006035/en/1538478/5/janux-logo-web_page_01.jpg)
![](https://mms.businesswire.com/media/20221012005257/en/1538478/5/janux-logo-web_page_01.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/shortsqueeze1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/29/image_6.jpg?width=1200&height=800&fit=crop)
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20220923005057/en/1538478/5/janux-logo-web_page_01.jpg)
Janux Therapeutics Appoints Brenda Van Vreeswyk as Head of Human Resources
September 23, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image24.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220922005170/en/1538478/5/janux-logo-web_page_01.jpg)
Janux Therapeutics Appoints Winston Kung to Board of Directors
September 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220831005178/en/1538478/5/janux-logo-web_page_01.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/image_6.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.